Staphylococcus biofilm components as targets for vaccines and drugs

International Journal of Artificial Organs

Volumn 30, Issue 9, 2007, Pages 813-819

  Visai, L ^a   Arciola, C R ^b,c   Pietrocola, G ^a   Rindi, S ^a   Olivero, P ^a   Speziale, Pietro ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Adhesins; Biofilm; Staphylococcus; Vaccine

Indexed keywords

BACTERIA; BIOFILMS;

ADHESIN; ANTIBIOTIC TREATMENT; EPIDERMIDIS; FOREIGN BODIES; MULTI-LAYERED; NOSOCOMIAL INFECTION; PREDISPOSING FACTORS; S. AUREUS; STAPHYLOCOCCUS; THERAPEUTIC STRATEGY;

VACCINES;

ADHESIN; BACTERIAL VACCINE; BSYX A110; CLFA ANTIBODY; DIPHTHERIA TOXIN; DNA VACCINE; LIPOTHEICOIC ACID MONOCLONAL ANTIBODY; LYSOSTAPHIN; MONOCLONAL ANTIBODY; POLYSACCHARIDE INTERCELLULAR ADHESIN; SDRG ANTIBODY; TEICHOIC ACID; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBODY TITER; ARTHRITIS; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BIOFILM; CELL DENSITY; CELL DISRUPTION; DEVICE INFECTION; DRUG CONJUGATION; DRUG TARGETING; FOREIGN BODY; GENE EXPRESSION REGULATION; HOST SUSCEPTIBILITY; MOLECULAR MECHANICS; NONHUMAN; PERSISTENT INFECTION; PHAGOCYTOSIS; QUORUM SENSING; REVIEW; RISK REDUCTION; SEPSIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; VACCINATION;

EID: 36049008365     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000911     Document Type: Review

References (46)

1. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs 2005; 28: 1062-8.
2. Mack D, Rohde H, Harris LG, Davies AP, Horstkotte MA, Knobloch JK. Biofilm formation in medical device-related infection. Int J Artif Organs 2006; 29: 343-59.
3. Heilmann C, Hussain M, Peters G, Götz F. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol 1997; 24: 1013-24.
4. Veenstra GJ, Cremers FF, van Dijk H, Fleer A. Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacteriol 1996; 178: 537-41.
5. Foster SJ. Molecular characterization and functional analysis of the major autolysin of Staphylococcus aureus 8325/4. J Bacteriol 1995; 177: 5723-5.
6. Hartford OM, Warm ER, Höök M, Foster TJ. Identification of residues in the Staphylococcus aureus fibrinogen-binding MSCRAMM clumping factor A (CIfA) that are important for ligand binding. J Biol Chem 2001; 276: 2466-73.
7. Colque-Navarro P, Palma M, Söderquist B; Flock JI, Möllby R. Antibody Responses in Patients with Staphylococcal Septicemia against Two Staphylococcus aureus Fibrinogen Binding Proteins: Clumping Factor and an Extracellular Fibrinogen Binding Protein. Clin Diagn Lab Immunol 2000; 7: 14-20.
8. Wolz C, Goerke C, Landmann R, Zimmerli W, Fluckiger U. Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection. Infect Immun 2002; 70: 2758-62.
9. Siboo IR, Cheung AL, Bayer AS, Sullam PM. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun 2001; 69: 3120-7.
10. Schwarz-Linek U, Höök M, Potts JR. The molecular basis of fibronectin-mediated bacterial adherence to host cells. Mol Microbiol 2004; 52: 631-41.
11. Wann ER, Gurusiddappa S, Höök M. The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen. J Biol Chem 2000; 275: 13863-71.
12. Davis SL, Gurusiddappa S, McCrea KW, Perkins S, Höök M. SdrG, a fibrinogen-binding bacterial adhesin of the microbial surface components recognizing adhesive matrix molecules subfamily from Staphylococcus epidermidis, targets the thrombin cleavage site in the Bbeta chain. J Biol Chem 2001; 276: 27799-805.
13. Arciola CR, Bustanji Y, Conti M, Campoccia D, Baldassarri L, Samori B, Montanaro L. Staphylococcus epidermidis-fibronectin binding and its inhibition by heparin. Biomaterials 2003; 24: 3013-9.
14. Hussain M, Heilmann C, Peters G, Herrmann M. Teichoic acid enhances adhesion of Staphylococcus epidermidis to immobilized fibronectin. Microb Pathog 2001; 31: 261-70.
15. Heilmann C, Thumm G, Chhatwal GS, Hartleib J, Uekotter A, Peters G. Identification and characterization of a novel autolysin (Aae) with adhesive properties from Staphylococcus epidermidis. Microbiology 2003; 149: 2769-78.
16. Williams RJ, Henderson B, Sharp LJ, Nair SP. Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infect Immun 2002; 70: 6805-10.
17. Mack D, Fischer W, Krokotsch A, Leopold K, Hartmann R, Egge H, Laufs R. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 1996; 178: 175-83.
18. Joyce JG, Abeygunawardana C, Xu Q, Cook JC, Hepler R, Przysiecki CT, Grimm KM, Roper K, Ip CC, Cope L, Montgomery D, Chang M, Campie S, Brown M, McNeely TB, Zorman J, Maira-Litran T, Pier GB, Keller PM, Jansen KU, Mark GE. Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus. Carbohydr Res 2003; 338: 903-22.
19. Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR, Otto M. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 2004; 279: 54881-6.
20. Cucarella C, Solano C, Valle J, Amorena B, Lasa I, Penades JR. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 2001; 183: 2888-96.
21. Arrizubieta MJ, Toledo-Arana A, Amorena B, Penades JR, Lasa I. Calcium inhibits bap-dependent multicellular behavior in Staphylococcus aureus. J Bacteriol 2004; 186: 7490-8.
22. Cucarella C, Tormo MA, Knecht E, Amorena B, Lasa I, Foster TJ, Penades JR. Expression of the biofilm-associated protein interferes with host protein receptors of Staphylococcus aureus and alters the infective process. Infect Immun 2002; 70: 3180-6.
23. Tormo MA, Knecht E, Gotz F, Lasa I, Penades JR. Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer? Microbiology 2005; 151: 2465-75.
24. Bowden MG, Chen W, Singvall J, Xu Y, Peacock SJ, Valtulina V, Speziale P, Hook M. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis. Microbiology 2005; 151: 1453-64.
25. Lasa I, Penades JR. Bap: a family of surface proteins involved in biofilm formation. Res Microbiol 2006; 157: 99-107.
26. Hussain M, Herrmann M, von Eiff C, Perdreau-Remington F, Peters G. A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun 1997; 65: 519-24.
27. Roche FM, Meehan M, Foster TJ. The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiology 2003; 149: 2759-67.
28. Banner MA, Cunniffe JG, Macintosh RL, Foster TJ, Rohde H, Mack D, Hoyes E, Derrick J, Upton M, Handley PS. Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein. J Bacteriol 2007; 189: 2793-804.
29. Rohde H, Burdelski C, Bartscht K, Hussain M, Buck F, Horstkotte MA, Knobloch JK, Heilmann C, Herrmann M, Mack D. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol Microbiol 2005; 55: 1883-95.
30. Corrigan RM, Rigby D, Handley P, Foster TJ. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology 2007; 153(Pt 8): 2435-46.
31. Vandecasteele SJ, Peetermans WE, R Merckx R, Rijnders BJ, Van Eldere J. Reliability of the ica, aap and atlE genes in the discrimination between invasive, colonizing and contaminant Staphylococcus epidermidis isolates in the diagnosis of catheter-related infections. Clin Microbiol Infect 2003; 9: 114-9.
32. Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 2001; 184: 1572-80.
33. Brouillette E, Lacasse P, Shkreta L, Belanger J, Grondin G, Diarra MS, Fournier S, Talbot BG. DNA immunization against the clumping factor A (ClfA) of Staphylococcus aureus. Vaccine 2002; 20: 2348-57.
34. Vernachio J, Bayer AS, Le T, Chai YL, Prater B, Schneider A, Ames B, Syribeys P, Robbins J, Patti JM. Anticlumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob Agents Chemother 2003; 47: 3400-6.
35. Hall AE, Domanski PJ, Pater PR, Vernachio JH, Syribeys PJ, Gorovits EL, Johnson MA, Ross JM, Hutchins JT, Patti JM. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun 2003; 71: 6864-70.
36. Maira-Litran T, Kropec A, Goldmann D, Pier GB. Biotogic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine 2004; 22: 872-9.
37. Li H, Xu L, Wang J, Wen Y, Vuong C, Otto M, Gao Q. Conversion of Staphylococcus epidermidis strains from commensal to invasive by expression of the ica locus encoding production of biofilm exopolysaccharide. Infect Immun 2005; 73: 3188-91.
38. Toledo-Arana A, Merino N, Vergara-Irigaray M, Debarbouille M, Penades JR, Lasa I. Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the adRS two-component system. J Bacteriol 2005; 187: 5318-29.
39. Sun D, Accavitti MA, Bryers JD. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clin Diagn Lab Immunol 2005; 12: 93-100.
40. Kaplan JB, Ragunath C, Velliyagounder K, Fine DH, Ramasubbu N. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2004; 48: 2633-6.
41. Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 2003; 47: 3407-14
42. Otto M. Quorum-sensing control in Staphylococci: a target for antimicrobial drug therapy? FEMS Microbiol Lett. 2004; 241: 135-41.
43. Vadyvaloo V, Otto M. Molecular genetics of Staphylococcus epidermidis biofilms on indwelling medical devices. Int J Artif Organs 2005; 28: 1069-78.
44. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 2004; 186: 1838-50.
45. Vuong C, Saenz HL, Gotz F, Otto M. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis 2000; 182: 1688-93.
46. Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J Infect Dis 2003; 188: 706-18.